Showing 1 - 20 results of 21 for search 'D. Yu. Veltishchev', query time: 0.44s Refine Results
  1. 1
    Possibilities of using Tanakan ® in therapy for generalized anxiety syndrome
    by D. Yu. Veltishchev
    Published 2010-06-01
    Get full text
    Article
  2. 2
    Neurasthenia: history and the present
    by D. Yu. Veltishchev
    Published 2011-12-01
    Get full text
    Article
  3. 3
    MENTAL DISORDERS IN PATIENTS WITH RHEUMATIC DISEASES: DIAGNOSIS AND TREATMENT
    by T. A. Lisitsyna, D. Yu. Veltishchev
    Published 2015-10-01
    Get full text
    Article
  4. 4
    Stressors and depressive disorders in rheumatic diseases
    Get full text
    Article
  5. 5
    THE CLINICAL AND PATHOGENETIC RELATIONSHIP BETWEEN BEHCET'S DISEASE AND MENTAL DISORDERS
    Get full text
    Article
  6. 6
    NARUShENIYa SNA U BOL'NYKh REVMATOIDNYM ARTRITOM I SISTEMNOY KRASNOY VOLChANKOY: EFFEKTIVNOST' I BEZOPASNOST' PREPARATA ZOLPIDEM (SANVAL)
    Get full text
    Article
  7. 7
    STRESS FACTORS AND MENTAL DISORDERS IN SJOGREN'S DISEASE: MODERN TRENDS IN RESEARCH
    Get full text
    Article
  8. 8
    Psychiatric aspects of spondyloarthritis
    Get full text
    Article
  9. 9
    Interleukin 6 as a pathogenic factor mediating clinical manifestations and a therapeutic target for rheumatic diseases and depressive disorders
    Get full text
    Article
  10. 10
    THE IMPACT OF ADEQUATE PSYCHOPHARMACOTHERAPY ON THE EFFICIENCY OF TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Get full text
    Article
  11. 11
    EFFECTS OF SYNTHETIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS, BIOLOGICAL AGENTS, AND PSYCHOPHARMACOTHERAPY ON THE MENTAL DISORDERS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Get full text
    Article
  12. 12
    Chronic stress and mental disorders in patients with systemic scleroderma: Results of an interdisciplinary study
    Get full text
    Article
  13. 13
    FACTORS INFLUENCING THE EFFICIENCY OF THERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS: THE ROLE OF COMORBID MENTAL AND SOMATIC DISEASES
    Get full text
    Article
  14. 14
    Depression and severity of articular destruction in patients with rheumatoid arthritis
    Get full text
    Article
  15. 15
    FACTORS ASSOCIATED WITH ANXIETY AND DEPRESSION SPECTRUM DISORDERS IN BEHCHET’S DISEASE
    Get full text
    Article
  16. 16
    Mental disorders and cognitive impairment in patients with antiphospholipid syndrome
    Get full text
    Article
  17. 17
    Objective: to specify the frequency and pattern of mental disorders in patients with rheumatoid arthritis (RA) and their association with a number of demographic parameters, stressors, inflammatory activity, duration of RA and its therapy, pain, and concomitant cardiovascular diseases (CVD).Subject and methods. One hundred and sixteen patients with verified RA were examined; 86% were women with a median age of 50 years (range, 41 to 55 years) and a median RA duration of 94.5 months (range, 45 to 228 months). Disease activity was assessed using the DAS 28 scoring system; the Brief Pain Inventory (BPI) was used for pain assessment. CVD was diagnosed by a cardiologist applying echocardiography, Doppler ultrasound, and 24-hour and blood pressure monitoring. Mental disorders were identified by a psychiatrist in accordance with ICD-10, by employing a number of psychiatric and psychological scales.Results. Mental disorders were found in 86% of the patients. There was a preponderance (85%) of anxiety-depressive spectrum disorders (ADSD): depressive episode (37%), including that within recurrent depressive disorder (19%); dysthymia (23%); adjustment disorders (16%); and generalized anxiety disorder (9%). Moderate cognitive impairment was revealed in 52% of the patients with ADSD. Schizophrenia was detected in 1%; 76 % of the RA patients had sleep disorders; 63 and 52% reported a stressful event at the onset of RA or before its exacerbation, respectively. The patients with ADSD did not differ from those without ADSD in age, gender, disease duration and activity, but they had more frequently aseptic bone necroses (ABN), X-ray stage IV, Class III functional insufficiency (FI), higher severity index and HAQ index. The patients with ADSD experienced stronger pain (p < 0.05). They took glucocorticoids for a shorter time (p < 0.05). Basic anti-inflammatory drugs were taken by the patients with and without ADSD at a similar frequency, but the patients with ADSD received methotrexate less often. ADSD was more common in patients with RA and CVD (angina pectoris, atherosclerosis, acute cerebrovascular insufficiency). Conclusion. Mental disorders with a predominance of ADSD are typical of the majority of patients with RA. Stressful events often precede the onset of RA and its exacerbation. The incidence of ADSD does not depend on age, gender, and disease duration and activity, but correlates with joint destructive changes (ABN and X-ray stage IV), pain intensity, FI, severity index and HAQ, less aggressive therapy for RA, and CVD.
    Get full text
    Article
  18. 18
    Chronic pain and depression in patients with rheumatoid arthritis: results of five - year follow - up
    Get full text
    Article
  19. 19
    Proinflammatory cytokines and depression in rheumatoid arthritis
    Get full text
    Article
  20. 20
    Comparative analysis of anxiety-depressive spectrum disorders in patients with rheumatic diseases
    Get full text
    Article
Search Tools: Get RSS Feed — Email this Search